WallStreetZenWallStreetZen

NASDAQ: SNDX
Syndax Pharmaceuticals Inc Stock Ownership - Who owns Syndax Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Syndax Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dennis PodlesakDirector2025-08-1819,200$15.84
$304.17kSell
Dennis PodlesakDirector2025-08-1819,200$7.20
$138.24kBuy
Dennis PodlesakDirector2025-08-1519,200$15.54
$298.41kSell
Dennis PodlesakDirector2025-08-1519,200$7.20
$138.24kBuy
Dennis PodlesakDirector2025-08-1419,200$14.19
$272.52kSell
Dennis PodlesakDirector2025-08-1419,200$7.20
$138.24kBuy
Keith A. GoldanChief Financial Officer2025-07-311,226$8.43
$10.34kBuy
Michael A. MetzgerChief Executive Officer2025-07-167,534$9.29
$69.95kSell
Keith A. GoldanChief Financial Officer2025-07-161,296$9.29
$12.03kSell
Keith KatkinDirector2025-05-1910,000$9.11
$91.12kBuy

1 of 2

SNDX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SNDX insiders and whales buy or sell their stock.

SNDX Shareholders

What type of owners hold Syndax Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc12.14%10,456,907$165.95MInstitution
Kynam Capital Management LP9.89%8,520,000$135.21MInstitution
Goldman Sachs Group Inc6.73%5,797,195$92.00MInstitution
Vanguard Group Inc5.84%5,033,934$79.89MInstitution
Eversept Partners LP4.72%4,065,355$64.52MInstitution
Bank Of America Corp4.46%3,838,872$60.92MInstitution
State Street Corp4.00%3,442,752$54.64MInstitution
Stempoint Capital LP2.75%2,372,634$37.65MInstitution
Franklin Resources Inc2.74%2,359,677$37.45MInstitution
Luke Evnin2.52%2,168,691$34.42MInsider

1 of 3

SNDX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SNDX91.99%8.01%Net BuyingNet Selling
ETNB90.91%9.09%Net BuyingNet Selling
INVA59.66%40.34%Net Selling
SPRY48.51%51.49%Net SellingNet Selling
ABCL35.98%44.65%Net Buying
View Top Biotech Stocks

Syndax Pharmaceuticals Stock Ownership FAQ

Who owns Syndax Pharmaceuticals?

Syndax Pharmaceuticals (NASDAQ: SNDX) is owned by 118.08% institutional shareholders, 10.29% Syndax Pharmaceuticals insiders, and 0.00% retail investors. Luke Evnin is the largest individual Syndax Pharmaceuticals shareholder, owning 2.17M shares representing 2.52% of the company. Luke Evnin's Syndax Pharmaceuticals shares are currently valued at $33.39M.

If you're new to stock investing, here's how to buy Syndax Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.